Suppositional area for the search of bacterial products for anticancer therapy

被引:0
|
作者
Abashina, Tatiana [1 ]
Laurinavichius, Kestutis [1 ]
Vainshtein, Mikhail [1 ,2 ]
机构
[1] Russian Acad Sci, Inst Biochem & Physiol Microorganisms, Prospekt Nauki 5, Pushchino 142290, Moscow Region, Russia
[2] Pushchino State Inst Nat Sci, Prospekt Nauki 5, Pushchino 142290, Moscow Region, Russia
关键词
CANCER; ANTIBIOTICS;
D O I
10.1016/j.mehy.2016.04.036
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
It is well-known that bacteria can produce compounds which show anticancer effects. In present time, it is impossible to check all bacterial species on their possible production of anticancer compounds (AC) under different conditions. Thus, it is necessary to limit the area for search of bacterial products for the anticancer therapy. We propose that production of AC by bacteria is a part of microbial biological strategy under natural conditions. We propose that bacteria in soils, in water and on plants do not meet human tumors and their AC serve for the competition with eukaryotic organisms. Most probably, an epiphytic growth of bacilli is accompanied with production of compounds inhibiting eukaryotes. According to awaited profit for the AC-producing bacteria, the epiphytic groups of bacilli show inhibition of mycelial fungi which are a natural model of eukaryotic cells. An example of strain isolation and a primary test is presented. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:54 / 56
页数:3
相关论文
共 50 条
  • [21] Natural Products as Anticancer Agents
    Varghese, Ruby
    Dalvi, Yogesh B.
    CURRENT DRUG TARGETS, 2021, 22 (11) : 1272 - 1287
  • [22] Anticancer Properties of Natural Products
    Zupko, Istvan
    Jaeger, Walter
    Topcu, Zeki
    Wu, Chin-Chung
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [23] Considering the critical interface between tumor cells and stromal cells in the search for targets for anticancer therapy
    Blavier, L
    DeClerck, YA
    CANCER CELL, 2005, 7 (05) : 408 - 409
  • [24] Quinolones in the Search for New Anticancer Agents
    Batalha, Pedro Netto
    Bastos Vieira de Souza, Maria Cecilia
    Pena-Cabrera, Eduardo
    Cruz Cruz, David
    Santos Boechat, Fernanda da Costa
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (39) : 6009 - 6020
  • [25] Anticancer Activity of Bacterial Proteins and Peptides
    Karpinski, Tomasz M.
    Adamczak, Artur
    PHARMACEUTICS, 2018, 10 (02):
  • [26] Bacterial Inactivation of the Anticancer Drug Doxorubicin
    Westman, Erin L.
    Canova, Marc J.
    Radhi, Inas J.
    Koteva, Kalinka
    Kireeva, Inge
    Waglechner, Nicholas
    Wright, Gerard D.
    CHEMISTRY & BIOLOGY, 2012, 19 (10): : 1255 - 1264
  • [27] Anticancer and immunosuppressive properties of bacterial prodiginines
    Williamson, Neil R.
    Fineran, Peter C.
    Gristwood, Tamzin
    Chawrai, Suresh R.
    Leeper, Finian J.
    Salmond, George P. C.
    FUTURE MICROBIOLOGY, 2007, 2 (06) : 605 - 618
  • [28] Sphingolipids in anticancer therapy
    Padrón, JM
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (07) : 755 - 770
  • [29] ANTICANCER THERAPY - DISCUSSION
    HILARIS, BS
    FOLEY, KM
    GRALLA, RJ
    DEELEY, TJ
    PAULSON, DL
    ADVANCES IN PAIN RESEARCH AND THERAPY, 1982, 4 : 123 - 124
  • [30] ANTICANCER THERAPY - DISCUSSION
    PEZZUOLI, G
    PAULSON, DL
    MARTINI, N
    SARTORI
    PALETTO, AE
    ROOMANS
    RICCI
    ADVANCES IN PAIN RESEARCH AND THERAPY, 1982, 4 : 81 - 85